Ramanan, A V, Hampson, L V, Lythgoe, H, Jones, A P, Hardwick, B, Hind, H, Jacobs, B, Vasileiou, D, Wadsworth, I, Ambrose, N, Davidson, J, Ferguson, P J, Herlin, T, Kavirayani, A, Killeen, O G, Compeyrot-Lacassagne, S, Laxer, R M, Roderick, M, Swart, J F, Hedrich, C M & Beresford, M W 2019, ' Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design : An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO ', PLOS ONE, vol. 14, no. 6, e0215739 . https://doi.org/10.1371/journal.pone.0215739 PLOS ONE PLoS ONE, Vol 14, Iss 6, p e0215739 (2019) PLoS ONE Ramanan, A V, Hampson, L V, Lythgoe, H, Jones, A P, Hardwick, B, Hind, H, Jacobs, B, Vasileiou, D, Wadsworth, I, Ambrose, N, Davidson, J, Ferguson, P J, Herlin, T, Kavirayani, A, Killeen, O G, Compeyrot-Lacassagne, S, Laxer, R M, Roderick, M, Swart, J F, Hedrich, C M & Beresford, M W 2019, ' Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design : An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO ', PLoS ONE, vol. 14, no. 6, e0215739 . https://doi.org/10.1371/journal.pone.0215739 PLoS ONE, 14(6). Public Library of Science